Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CNTMF - Cansortium Inc. (CNTMF) Q1 2023 Earnings Call Transcript


CNTMF - Cansortium Inc. (CNTMF) Q1 2023 Earnings Call Transcript

2023-05-31 21:37:04 ET

Cansortium Inc. (CNTMF)

Q1 2023 Earnings Conference Call

May 31, 2023 16:30 ET

Company Participants

Robert Beasley - Chief Executive Officer

Jeff Batliner - Chief Financial Officer

Conference Call Participants

Russell Stanley - Beacon Securities

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to Cansortium’s First Quarter 2023 Conference Call. Joining us today are the company’s CEO, Robert Beasley and the company’s CFO, Jeff Batliner. [Operator Instructions] As a reminder, this conference call is being recorded and will be available for replay in the Investors section of the company’s website at www.getfluent.com.

Please note that certain subjects discussed on this call, including answers the company may provide to questions, may include content that is forward-looking in nature and therefore, subject to risks and uncertainties and other factors, which could cause actual future results or performance to differ materially from any implied expectations. Such risks surrounding forward-looking statements are all outlined in detail within the company’s regulatory filings, which can be found on sedar.com.

The company does not undertake to update or revise any forward-looking statements, except to the extent required by applicable securities laws in Canada. In addition, during this call, the company will refer to supplemental non-IFRS accounting measures, included adjusted EBITDA, which do not have any standardized meaning prescribed by IFRS. As a final reminder on today’s call, otherwise indicated, all dollar amounts are expressed in U.S. dollars.

I would now like to turn the conference over to Mr. Robert Beasley, the company’s CEO. Sir, please go ahead.

Robert Beasley

Thank you, Ariel and good afternoon everyone. We once again delivered double-digit revenue growth, adjusted EBITDA margin and expansion and strong cash flow generation in Q1 2023 despite the challenging landscape for the cannabis industry. We are continuing to see meaningful operational improvement in Pennsylvania and Florida and now working to expand our capabilities in Texas.

Turning to the first quarter operational highlights. In Florida, we delivered 10% year-over-year revenue growth in Q1. As mentioned in my last conference call in May, we recently opened 3 new stores in Florida, which helped drive our revenue improvement and are still planning to open 4 more stores by the end of the year. We’ve continued to gain market share in the state, bucking the trend faced by many of our competitors in Florida.

We are also now producing higher THC products on average as our cultivation improvements and recovery from the hurricane are now starting to bear fruit. This is important because our average – as the average THC increases, the harvest are now averaging 23% on average, with some harvest being well over 30%, our overall ratio of high-quality flower is increasing. This enables us to sell more products at higher price points and stock our shelves with more A and B quality grade product. Further to our cultivation in Florida, I am pleased to announce that we recently entered into a contract subject to financing to acquire a property that will become a new 70,000-square-foot cultivation facility and a 2.5-acre greenhouse. We look forward to providing updates on this project later as the year progresses.

Finally, we just recently announced that we plan to move our headquarters from Miami to Tampa, Florida, a change which we expect to finalize in September. This move will see the company create more than 30 key corporate jobs in Tampa with an average salary of $100,000. In addition, we are taking out double the square footage of commercial office space for about $500 less per month. So getting more for less in the move to Tampa, it also consolidates our management team in the proximity of our cultivation center.

Turning to Pennsylvania. We generated strong sales growth in the state without opening any additional stores. This really is a reflection of our optimization efforts with respect to new product introductions and inventory management. Earlier this year, we hired a new inventory specialist that has completely reorganized the inventory management in the state. This more targeted approach has LED to organic sales growth along with improved gross margins and adjusted EBITDA. In Florida, we’ve also introduced chocolates and drink powder, which are showing early success.

Finally, in Texas, two pieces of legislation recently failed that would have decriminalized cannabis and expanded the state’s medical cannabis program. Although we are disappointed in the Texas Senate’s failure to take action, we commend Texas representative Joe Moody and representative Stephanie Klick and the representative authors and cosponsors for their continued work to enact meaningful legislation on cannabis reform. We continue to believe that Texas has the potential to become a top cannabis market in the long term and our first-mover advantage remains as we are still one of only three license holders in the state.

Our Texas business is now fully operational and we continue to grow – gain ground. We are selling to other operators in the wholesale market and have a suite of products, existing patients and ongoing retail sales. Despite the lack of regulatory or legislative movement, we believe the market is now starting to develop at a manageable pace. In the near term in Texas, we will continue to build out our operations in Houston and expand our delivery capabilities to service patients in Austin and San Antonio because we believe that all Americans, including Texas, deserve access to safe tested medical cannabis.

As we near the halfway point of 2023, we look forward to further driving growth and profitability in our existing markets through new store openings. We continue to cultivation and manufacturing and increased optimization and operating efficiencies. We are constantly evaluating opportunities in new markets, and we will remain optimistic with our M&A strategy. In the meantime, we are continuing to execute on our organic strategy and well on our way to delivering a year of strong growth in cash flow generation.

I’ll now hand it over to Jeff Batliner to walk through the financial highlights. Jeff?

Jeff Batliner

Thank you, Robert, and good afternoon, everyone. As Robert mentioned, we’re proud to report another period of strong improvement across all key financial metrics. Please note all figures are in U.S. dollars and all variance commentary is on a year-over-year basis, unless otherwise specified. Revenue increased 12% in Q1 to $22.1 million compared to $19.7 million in Q1 of 2022. The increase was largely driven by growth in Florida with three additional stores compared to the prior year as well as a new store in Pennsylvania. The growth was also driven by improved store level economics.

Adjusted gross profit for the quarter increased 22% to $14.1 million or 63.9% of revenue compared to $11.5 million or 58.6% of revenue. With the increase in adjusted gross profit due not only to higher revenues, but also to efficiency gains in our cultivation and production operations, improved processes have lowered costs. Operating expenses in the first quarter decreased 3% to $8.4 million compared to $8.7 million, with the decrease primarily due to lower general and administrative expenses. As a percentage of revenue, operating expenses improved significantly to 38% compared to 44% of revenue last year.

Adjusted EBITDA for the quarter increased 56% to $9.7 million compared to $6.2 million, with the increase primarily driven by revenue growth, gross margin expansion and lower OpEx. Cash from operations improved 20% to $5.1 million compared to $4.3 million in Q1 of 2022. And at March 31, 2023, the company had approximately $9.5 million of cash and cash equivalents and $57.9 million of total debt, with approximately 296 million shares outstanding.

That concludes our financial highlights. Operator, we will now open the call for Q&A.

Question-and-Answer Session

Operator

Thank you. [Operator Instructions] Our first question comes from Russell Stanley of Beacon Securities. Please go ahead.

Russell Stanley

Good afternoon. Congrats for solid and an excellent quarter. Just wondering your thoughts on margins for the rest of the year given the bounce back we saw this quarter.

Robert Beasley

I’m sorry, Russell, the middle part of your question kind of faded on me. What was the middle part?

Russell Stanley

Apologies. So I was asking what your thoughts are on margins are for the rest of the year? We saw a great bounce back in this quarter from Q4, some anomalies in Q4 and again, strong improvement this quarter. So just wondering how you’re thinking about margins for the rest of ‘23? You’ve got efficiency improvements planned but pricing pressure in Florida. Just wondering if you expect any major changes on the margin front throughout the rest of ‘23?

Robert Beasley

Thank you for the question. We do not expect major change. We expect continual increase in the competition, and we’re trying to match that price compression by continuing efficiencies. We’re now addressing some of the efficiencies in the cultivation side as we speak. We’re working to get – to continue to increase margin to offset the price compression we expect to see. Although we believe that some of the competitors have stalled, if you look at the sales in Florida, a lot of the growth has completely stalled out with many of the up-and-coming companies for various reasons, most all related to capital.

So I do expect maybe Q2 to be a little flat. Q2 is always a little flat for us. And then we have the summer, of course, and then we will expect a strong Q3, Q4 finish. So I think the pattern of our development and revenue generation will follow last year’s pattern without much interruption. We may be a little lower in Q2 or a little flatter due to some of the market changes that have occurred in Q1 and rolling into the first of this year. I also note that there was a drop in from Q4 to Q1, but really if you look at the adjustments that were taken on the biologicals and so forth in those financials, that application of those adjustments solely to Q4 caused the numbers to look at a little bit different and a little bit tilted from what they actually were. But all in all, I think we’re going to follow the same ebb and flow pattern of the year that we did last year.

Russell Stanley

That’s great. Thank you for that color. Maybe if I could ask around the property purchase you mentioned in the press release in Florida. Just wondering if you can elaborate on the – on some of the details around the purchase cost and the associated CapEx and what the timelines might be to first harvest?

Robert Beasley

Sure. I’ve preached from the beginning that remaining in balance is the key to a vertical operator. And as you’ve noted in the last four, five quarters, our expansion has been in the storefront, in the store footprint area. And now we’re reaching a point where we have adequate inventory and inventory compression to be competitive in sales. But as we add the next four or five stores, we need to pay attention to the production side. And so it’s time now to develop out a project which will serve production and input to feed the – out to the expanded stores we have now and then allow us to grow again on the storefront. The cost – the acquisition cost is $2.5 million. The first phase development cost is about another $12.5 million. And so you are looking at about a $15 million build-out for Phase 1 of the project. The neat thing about this property is it allows for incremental construction and build-out. It’s a campus with a series of existing buildings. And so rather than trying to do what is now traditional in cannabis and may be a mistake, which has plopped down a 300,000 square foot square building and try to build it out internally, this allows us to be incremental and adjust the output with the demand. The projected timeline, it’s going to be about 10 months to 12 months to get the facility in production. Again, I am trying to land that with about the time that our 35 and 36 store comes online. We are adequate in production all the way up to 35, 36. Right around there, we need to make sure that the next thing that happens is increased production so that a store also takes about eight months to build out so that we can continue to flow in development of stores. So, this is really just the balancing step and it’s time to pay attention to the feed material.

Russell Stanley

That’s excellent color. And maybe if I could, just on Phase 1, I guess how many additional stores would you be able to support over the 36 stores you can currently handle?

Robert Beasley

And there is an interesting ratio relationship there of how many stores versus increased sales per store. So, the best way I can say it is that at the current rate of sales, the increased production would take us to 42 stores. Now, the marketing team is always working to increase the rate of sales. We do have the concentrate products coming online this quarter. We increased – we expect that to be a SKU segment serving a population that we haven’t yet served. So, we could see a pretty significant rate of sales. Problem with concentrate, of course as they are concentrated, so it takes more biomass to feed concentrates as a product. So, that may cause us to more rapidly consume our in-feed, but it will increase sales, short answer under current rate of sales, about 42 stores.

Russell Stanley

That’s great. Maybe if I could add in one more and get back in the queue on Pennsylvania, you talked about moving towards a more targeted inventory management strategy. Just wondering if you can, I guess elaborate on what that means and how that’s helped on – help drive organic growth?

Robert Beasley

Sure. I could put it in the simple terms, I know how to explain it, which is if you think about our three stores and in particularly two stores of them that were older and their inventories being a gas tank, we were only selling and resupplying the top quarter of the tank. We had about three quarters of our inventory that was kind of stale, stuck and represented trapped capital dollars in inventory in the system. The products just weren’t good sellers or trending wise, they were no longer new. And so what we did was the inventory specialist came onboard, dug into that tank, that three-quarter tank of older products and created incentives, sales discounts, gave it away if they had to, to get it out to recover those dollars, which then allowed us more inventory purchasing power. And using the same analogy, we are now sitting in a scenario where we are using three quarters of our tank. So, the balance, if you would of inventory is using a full three quarters of our ability of purchasing power with now only a quarter of the tank sitting in kind of inventory that’s not moving as fast. So, just restructuring how we bought, what we did and first starting with flushing out the old was a key critical step.

Russell Stanley

That’s great. I will get back in the queue, but congrats on the quarter again.

Robert Beasley

Thank you.

Operator

This concludes the question-and-answer session as well as today’s conference call. You may disconnect your lines. Thank you for participating and have a pleasant day.

For further details see:

Cansortium Inc. (CNTMF) Q1 2023 Earnings Call Transcript
Stock Information

Company Name: Cansortium Inc
Stock Symbol: CNTMF
Market: OTC
Website: cansortium.com

Menu

CNTMF CNTMF Quote CNTMF Short CNTMF News CNTMF Articles CNTMF Message Board
Get CNTMF Alerts

News, Short Squeeze, Breakout and More Instantly...